These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 2824170)
1. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Sandström EG; Kaplan JC Drugs; 1987 Sep; 34(3):372-90. PubMed ID: 2824170 [TBL] [Abstract][Full Text] [Related]
2. Progress in the development of antiviral therapy for HTLV-III-associated diseases. Yarchoan R; Broder S Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232 [No Abstract] [Full Text] [Related]
3. Antiviral drugs for AIDS. Current status and future prospects. Sandström E Drugs; 1986 Jun; 31(6):463-6. PubMed ID: 2942386 [No Abstract] [Full Text] [Related]
5. Prospects of therapy for infections with human T-lymphotropic virus type III. Hirsch MS; Kaplan JC Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793 [TBL] [Abstract][Full Text] [Related]
7. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview. Clumeck N; Hermans P Am J Med; 1988 Aug; 85(2A):165-72. PubMed ID: 2457313 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy and immunologic reconstitution in AIDS. Fauci AS; Lane HC Ann Inst Pasteur Immunol; 1987; 138(2):261-8. PubMed ID: 2955796 [No Abstract] [Full Text] [Related]
9. [Experimental chemotherapy of AIDS]. Rada B Cas Lek Cesk; 1988 May; 127(22):677-83. PubMed ID: 3293790 [No Abstract] [Full Text] [Related]
10. Anti-AIDS agents show varying early results in vitro and in vivo. Riesenberg DE; Marwick C JAMA; 1985 Nov; 254(18):2521, 2527, 2529. PubMed ID: 2997490 [No Abstract] [Full Text] [Related]
11. [Chemotherapy and immunoprophylaxis of HIV infection]. Vogt M; Schooley RT; Hirsch MS Schweiz Rundsch Med Prax; 1986 Nov; 75(48):1471-5. PubMed ID: 2432642 [No Abstract] [Full Text] [Related]
12. Immunologic reconstitution in the acquired immunodeficiency syndrome. Lane HC; Fauci AS Ann Intern Med; 1985 Nov; 103(5):714-8. PubMed ID: 2996405 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). De Clercq E J Med Chem; 1986 Sep; 29(9):1561-9. PubMed ID: 2427720 [No Abstract] [Full Text] [Related]
14. Development of antiviral agents for the treatment of human immunodeficiency virus infection. Tartaglione TA; Collier AC Clin Pharm; 1987 Dec; 6(12):927-40. PubMed ID: 3322638 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients. Moroni M; Lazzarin A; Orlando G; Crocchiolo P; Castagna A; Verani P Chemioterapia; 1987 Jun; 6(2 Suppl):639-41. PubMed ID: 3509513 [No Abstract] [Full Text] [Related]
16. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. Montefiori DC; Robinson WE; Mitchell WM AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450 [TBL] [Abstract][Full Text] [Related]
17. Acyclovir-resistant herpes in AIDS treated with foscarnet. Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762 [No Abstract] [Full Text] [Related]
18. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921 [No Abstract] [Full Text] [Related]
19. The treatment of HIV infection. Richman DD AIDS; 1988; 2 Suppl 1():S137-42. PubMed ID: 2852501 [No Abstract] [Full Text] [Related]
20. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Chrisp P; Clissold SP Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]